FILANA THERAPEUTICS, INC. 8-K

What Happened Filana Therapeutics, Inc. (ticker: FLNA) filed a Form 8-K with the SEC on April 28, 2026 (Accession No. 0001437749-26-013638) and indicated that there were no items to report on the form. The filing does not disclose earnings, executive changes, mergers, acquisitions, or other material events.

Key Details

• Filing date: April 28, 2026; Accession No.: 0001437749-26-013638.
• The Form 8-K contains "No items reported" — no Item 2.02 (earnings/financial results), no Item 5.02 (executive changes), no Item 1.01 (merger/acquisition), etc.
• Ticker: FLNA; the filing is a current report to satisfy SEC disclosure requirements, not a disclosure of a specific event.

Why It Matters For investors, this filing means Filana has not reported any new material events requiring disclosure on this 8-K. In plain terms: there were no announced earnings, leadership changes, mergers, or other developments in this report. Investors should continue to monitor future SEC filings and company releases for material updates (earnings, revenue, CEO/CFO changes, or M&A activity).